H.I.G. BIOHEALTH PARTNERS
H.I.G. BioVentures invests in a broad range of life science companies across multiple sectors and stages of development. Their seasoned investment team has extensive and diverse experience in big pharma, small biotech, medical devices, diagnostics, basic science, clinical research, and technology transfer. They invest in companies developing novel products for significant unmet medical needs.
H.I.G. BIOHEALTH PARTNERS
Social Links:
Industry:
Biotechnology Life Science Venture Capital
Founded:
2011-01-01
Status:
Active
Contact:
214.855.2998
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Content Delivery Network Font Awesome Apache Euro JsDelivr
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Quaker BioVentures
Quaker BioVentures is a venture capital firm investing in life science companies. The firm leads investments across the spectrum of the
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-22 | Click Therapeutics | H.I.G. BioHealth Partners investment in Series B - Click Therapeutics | 52 M USD |
| 2020-05-27 | Arvelle Therapeutics | H.I.G. BioHealth Partners investment in Series A - Arvelle Therapeutics | 42.7 M USD |
| 2019-10-23 | Zerigo Health | H.I.G. BioHealth Partners investment in Series A - Zerigo Health | 18 M USD |
| 2019-07-16 | Exagen | H.I.G. BioHealth Partners investment in Venture Round - Exagen | 22.6 M USD |
| 2019-05-30 | Intact Vascular | H.I.G. BioHealth Partners investment in Series D - Intact Vascular | 25 M USD |
| 2019-02-18 | Arvelle Therapeutics | H.I.G. BioHealth Partners investment in Series A - Arvelle Therapeutics | 180 M CHF |
| 2018-06-15 | Iconic Therapeutics | H.I.G. BioHealth Partners investment in Venture Round - Iconic Therapeutics | 4.11 M USD |
| 2018-05-08 | Neurana Pharmaceuticals | H.I.G. BioHealth Partners investment in Series A - Neurana Pharmaceuticals | 60 M USD |
| 2018-04-16 | Intact Vascular | H.I.G. BioHealth Partners investment in Series C - Intact Vascular | 20 M USD |
| 2018-03-14 | On Target Laboratories | H.I.G. BioHealth Partners investment in Series B - On Target Laboratories | 4 M USD |